Foster BC - Search Results

1

Time-dependent interaction between lopinavir/ritonavir and fexofenadine.

van Heeswijk RP, Bourbeau M, Campbell P, Seguin I, Chauhan BM, Foster BC, Cameron DW. van Heeswijk RP, et al. Among authors: foster bc. J Clin Pharmacol. 2006 Jul;46(7):758-67. doi: 10.1177/0091270006288733. J Clin Pharmacol. 2006. PMID: 16809801 Clinical Trial.

2

The effect of ABCB1 polymorphism on the pharmacokinetics of saquinavir alone and in combination with ritonavir.

la Porte CJ, Li Y, Béïque L, Foster BC, Chauhan B, Garber GE, Cameron DW, van Heeswijk RP. la Porte CJ, et al. Among authors: foster bc. Clin Pharmacol Ther. 2007 Oct;82(4):389-95. doi: 10.1038/sj.clpt.6100157. Epub 2007 Mar 14. Clin Pharmacol Ther. 2007. PMID: 17361121 Clinical Trial.

3

Effect of high-dose vitamin C on hepatic cytochrome P450 3A4 activity.

van Heeswijk RP, Cooper CL, Foster BC, Chauhan BM, Shirazi F, Seguin I, Phillips EJ, Mills E. van Heeswijk RP, et al. Among authors: foster bc. Pharmacotherapy. 2005 Dec;25(12):1725-8. doi: 10.1592/phco.2005.25.12.1725. Pharmacotherapy. 2005. PMID: 16305291

4

Induction of zidovudine glucuronidation and amination pathways by rifampicin in HIV-infected patients.

Gallicano KD, Sahai J, Shukla VK, Seguin I, Pakuts A, Kwok D, Foster BC, Cameron DW. Gallicano KD, et al. Among authors: foster bc. Br J Clin Pharmacol. 1999 Aug;48(2):168-79. doi: 10.1046/j.1365-2125.1999.00987.x. Br J Clin Pharmacol. 1999. PMID: 10417493 Free PMC article. Clinical Trial.

5

The effect of β-carotene supplementation on the pharmacokinetics of nelfinavir and its active metabolite M8 in HIV-1-infected patients.

Sheehan NL, van Heeswijk RP, Foster BC, Akhtar H, Singhal N, Seguin I, DelBalso L, Bourbeau M, Chauhan BM, Boulassel MR, Burger DM, Lalonde RG, Cameron DW. Sheehan NL, et al. Among authors: foster bc. Molecules. 2012 Jan 12;17(1):688-702. doi: 10.3390/molecules17010688. Molecules. 2012. PMID: 22241465 Free PMC article. Clinical Trial.

6

In vitro activity of uva-ursi against cytochrome P450 isoenzymes and P-glycoprotein.

Chauhan B, Yu C, Krantis A, Scott I, Arnason JT, Marles RJ, Foster BC. Chauhan B, et al. Among authors: foster bc. Can J Physiol Pharmacol. 2007 Nov;85(11):1099-107. doi: 10.1139/Y07-106. Can J Physiol Pharmacol. 2007. PMID: 18066112

7

Inhibition of human cytochrome p450 metabolism by blended herbal products and vitamins.

Tam TW, Akhtar H, Arnason JT, Cvijovic K, Boon H, Cameron DW, Drouin CE, Jaeger W, Tsuyuki RT, Vohra S, Foster BC. Tam TW, et al. Among authors: foster bc. J Pharm Pharm Sci. 2011;14(1):1-16. doi: 10.18433/j3n30w. J Pharm Pharm Sci. 2011. PMID: 21501549 Free article.

8

Impact of African herbal medicines on antiretroviral metabolism.

Mills E, Foster BC, van Heeswijk R, Phillips E, Wilson K, Leonard B, Kosuge K, Kanfer I. Mills E, et al. Among authors: foster bc. AIDS. 2005 Jan 3;19(1):95-7. doi: 10.1097/00002030-200501030-00013. AIDS. 2005. PMID: 15627040

9

Modulation of human cytochrome P450 3A4 (CYP3A4) and P-glycoprotein (P-gp) in Caco-2 cell monolayers by selected commercial-source milk thistle and goldenseal products.

Budzinski JW, Trudeau VL, Drouin CE, Panahi M, Arnason JT, Foster BC. Budzinski JW, et al. Among authors: foster bc. Can J Physiol Pharmacol. 2007 Sep;85(9):966-78. doi: 10.1139/Y07-091. Can J Physiol Pharmacol. 2007. PMID: 18066144

10

In vitro activity of commercial valerian root extracts against human cytochrome P450 3A4.

Lefebvre T, Foster BC, Drouin CE, Krantis A, Livesey JF, Jordan SA. Lefebvre T, et al. Among authors: foster bc. J Pharm Pharm Sci. 2004 Aug 12;7(2):265-73. J Pharm Pharm Sci. 2004. PMID: 15367385 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

73 results

Search Page